(Q40664581)

22 September 2017

1 reference

title

Nitric oxide: basic science and clinical applications (English)

1 reference

22 September 2017

Kam PC

1

1 reference

PubMed ID

8017597

22 September 2017

Govender G

series ordinal

2

1 reference

PubMed ID

8017597

22 September 2017

language of work or name

English

0 references

publication date

1 June 1994

1 reference

22 September 2017

1 reference

22 September 2017

49

1 reference

22 September 2017

515-521

1 reference

22 September 2017

6

1 reference

Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor

22 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.1994.TB03525.X

Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.1994.TB03525.X

Endothelium-derived relaxing factor: basic review and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.1994.TB03525.X

Biochemistry of Nitric Oxide and Its Redox-Activated Forms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.1994.TB03525.X

Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.1994.TB03525.X

Role of nitric oxide synthesis in macrophage antimicrobial activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.1994.TB03525.X

The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.1994.TB03525.X

Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.1994.TB03525.X

Endothelium-derived relaxing factor is an endogenous vasodilator in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.1994.TB03525.X

Flow-dependent regulation of coronary vasomotor tone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.1994.TB03525.X

Endothelium-derived relaxing factor inhibits hypoxic pulmonary vasoconstriction in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.1994.TB03525.X

Endothelium-derived nitric oxide: the endogenous nitrovasodilator in the human cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.1994.TB03525.X

Glutamate, nitric oxide and cell-cell signalling in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.1994.TB03525.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.1994.TB03525.X

Peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.1994.TB03525.X

Nitric oxide (NO) and nociceptive processing in the spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.1994.TB03525.X

Implications of the NO/cGMP system for olfaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.1994.TB03525.X

Nitric oxide as a neuronal messenger

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.1994.TB03525.X

Nitric oxide: a pathogenetic factor in autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.1994.TB03525.X

Safety guidelines for use of nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.1994.TB03525.X

Inhibition of nitric oxide synthesis in septic shock: how much is beneficial?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.1994.TB03525.X

Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.1994.TB03525.X

Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.1994.TB03525.X

Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.1994.TB03525.X

Inhaled nitric oxide in persistent pulmonary hypertension of the newborn

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.1994.TB03525.X

Inhaled nitric oxide in congenital heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.1994.TB03525.X

Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.1994.TB03525.X

10.1111/J.1365-2044.1994.TB03525.X

21 January 2018

Identifiers

DOI

1 reference

22 September 2017

1 reference

PubMed ID

8017597